iBio Inc (IBIO)
2.67
+0.08
(+3.09%)
USD |
NYAM |
Nov 01, 16:00
2.71
+0.04
(+1.50%)
After-Hours: 20:00
iBio Total Liabilities (Quarterly): 7.41M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 7.41M |
March 31, 2024 | 25.29M |
December 31, 2023 | 24.82M |
September 30, 2023 | 24.47M |
June 30, 2023 | 25.83M |
March 31, 2023 | 27.00M |
December 31, 2022 | 32.98M |
September 30, 2022 | 36.20M |
June 30, 2022 | 35.92M |
March 31, 2022 | 35.99M |
December 31, 2021 | 35.85M |
September 30, 2021 | 43.21M |
June 30, 2021 | 38.40M |
March 31, 2021 | 37.87M |
December 31, 2020 | 38.08M |
September 30, 2020 | 37.21M |
June 30, 2020 | 37.58M |
March 31, 2020 | 38.26M |
December 31, 2019 | 36.90M |
September 30, 2019 | 37.10M |
June 30, 2019 | 28.13M |
March 31, 2019 | 28.77M |
December 31, 2018 | 29.22M |
September 30, 2018 | 29.87M |
June 30, 2018 | 26.92M |
Date | Value |
---|---|
March 31, 2018 | 26.88M |
December 31, 2017 | 27.03M |
September 30, 2017 | 27.14M |
June 30, 2017 | 27.10M |
March 31, 2017 | 27.75M |
December 31, 2016 | 27.04M |
September 30, 2016 | 27.39M |
June 30, 2016 | 27.56M |
March 31, 2016 | 27.75M |
December 31, 2015 | 1.538M |
September 30, 2015 | 1.565M |
June 30, 2015 | 1.263M |
March 31, 2015 | 1.254M |
December 31, 2014 | 1.475M |
September 30, 2014 | 1.218M |
June 30, 2014 | 0.395M |
March 31, 2014 | 1.213M |
December 31, 2013 | 1.664M |
September 30, 2013 | 1.653M |
June 30, 2013 | 4.286M |
March 31, 2013 | 2.684M |
December 31, 2012 | 3.088M |
September 30, 2012 | 3.420M |
June 30, 2012 | 3.596M |
March 31, 2012 | 3.801M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
7.41M
Minimum
Jun 2024
43.21M
Maximum
Sep 2021
32.59M
Average
35.99M
Median
Mar 2022
Total Liabilities (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 4.542M |
Palatin Technologies Inc | 10.85M |
Theriva Biologics Inc | 14.74M |
Oragenics Inc | 1.383M |
Nanoviricides Inc | 1.359M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 28.73M |
Shareholders Equity (Quarterly) | 21.32M |
Debt to Equity Ratio | 0.0461 |
Current Ratio | 4.081 |
Net Debt Paydown Yield | 13.98% |